257 related articles for article (PubMed ID: 36696895)
1. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
[TBL] [Abstract][Full Text] [Related]
2. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
[TBL] [Abstract][Full Text] [Related]
3. TWEAK and TRAF6 regulate skeletal muscle atrophy.
Kumar A; Bhatnagar S; Paul PK
Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):233-9. PubMed ID: 22366923
[TBL] [Abstract][Full Text] [Related]
4. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
Lala-Tabbert N; Lejmi-Mrad R; Timusk K; Fukano M; Holbrook J; St-Jean M; LaCasse EC; Korneluk RG
Skelet Muscle; 2019 May; 9(1):13. PubMed ID: 31126323
[TBL] [Abstract][Full Text] [Related]
5. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.
Hindi SM; Mishra V; Bhatnagar S; Tajrishi MM; Ogura Y; Yan Z; Burkly LC; Zheng TS; Kumar A
FASEB J; 2014 Mar; 28(3):1398-411. PubMed ID: 24327607
[TBL] [Abstract][Full Text] [Related]
6. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
7. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
[TBL] [Abstract][Full Text] [Related]
8. Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.
Yarar-Fisher C; Bickel CS; Kelly NA; Stec MJ; Windham ST; McLain AB; Oster RA; Bamman MM
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E754-61. PubMed ID: 26931128
[TBL] [Abstract][Full Text] [Related]
9. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.
Bhatnagar S; Mittal A; Gupta SK; Kumar A
J Cell Physiol; 2012 Mar; 227(3):1042-51. PubMed ID: 21567392
[TBL] [Abstract][Full Text] [Related]
10. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
11. The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.
Tajrishi MM; Sato S; Shin J; Zheng TS; Burkly LC; Kumar A
Biochem Biophys Res Commun; 2014 Apr; 446(4):1219-1224. PubMed ID: 24680686
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
Meijboom KE; Sutton ER; McCallion E; McFall E; Anthony D; Edwards B; Kubinski S; Tapken I; Bünermann I; Hazell G; Ahlskog N; Claus P; Davies KE; Kothary R; Wood MJA; Bowerman M
Skelet Muscle; 2022 Jul; 12(1):18. PubMed ID: 35902978
[TBL] [Abstract][Full Text] [Related]
13. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A
J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332
[TBL] [Abstract][Full Text] [Related]
14. PHD3 mediates denervation skeletal muscle atrophy through Nf-κB signal pathway.
Li F; Yin C; Ma Z; Yang K; Sun L; Duan C; Wang T; Hussein A; Wang L; Zhu X; Gao P; Xi Q; Zhang Y; Shu G; Wang S; Jiang Q
FASEB J; 2021 Apr; 35(4):e21444. PubMed ID: 33749901
[TBL] [Abstract][Full Text] [Related]
15. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
Dogra C; Changotra H; Wedhas N; Qin X; Wergedal JE; Kumar A
FASEB J; 2007 Jun; 21(8):1857-69. PubMed ID: 17314137
[TBL] [Abstract][Full Text] [Related]
16. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
17. Magnoflorine prevent the skeletal muscle atrophy via Akt/mTOR/FoxO signal pathway and increase slow-MyHC production in streptozotocin-induced diabetic rats.
Yadav A; Singh A; Phogat J; Dahuja A; Dabur R
J Ethnopharmacol; 2021 Mar; 267():113510. PubMed ID: 33141056
[TBL] [Abstract][Full Text] [Related]
18. The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.
Bhatnagar S; Kumar A
Curr Mol Med; 2012 Jan; 12(1):3-13. PubMed ID: 22082477
[TBL] [Abstract][Full Text] [Related]
19. Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration.
Pascoe AL; Johnston AJ; Murphy RM
Cell Mol Life Sci; 2020 Sep; 77(17):3369-3381. PubMed ID: 32200423
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors.
Hahn A; Kny M; Pablo-Tortola C; Todiras M; Willenbrock M; Schmidt S; Schmoeckel K; Jorde I; Nowak M; Jarosch E; Sommer T; Bröker BM; Felix SB; Scheidereit C; Weber-Carstens S; Butter C; Luft FC; Fielitz J
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):103-119. PubMed ID: 31441598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
